Skip to Main Content (Press Enter)
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
IT
EN
☰
UNIFIND
|
UNIFIND
unisr.it
IT
EN
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
☰
Pubblicazioni
ANNALS OF ONCOLOGY
Rivista
Codice:
E009451
ISSN:
0923-7534
Dati Generali
Dati Generali
Pubblicazioni (191)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy
Abstract
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
Articolo
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
Articolo
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy
Contributo in Atti di convegno
A MULTICENTER RETROSPECTIVE STUDY OF CHEMOTHERAPY IN ADULTS WITH EPENDYMOMA. GICNO (GRUPPO ITALIANO COOPERATIVO NEURO-ONCOLOGIA)
Abstract
A NON-INVASIVE MULTI-TARGET Q-DHPLC BASED DNA INTEGRITY ASSAY, CALPROTECTIN AND IFOBT FOR COLORECTAL CANCER SCREENING: A SINGLE CENTER COMPARISON ANALYSIS
Abstract
A PHASE II STUDY TO INVESTIGATE THE PREVALENCE OF INFECTIOUS AGENTS IN OCULAR ADNEXAE MARGINAL ZONE LYMPHOMA (OAMZL) AND THE EFFICACY OF ANTIBIOTIC THERAPY (IELSG#27 TRIAL)
Abstract
A RANDOMIZED PHASE II TRIAL OF TWO DIFFERENT FOUR DRUG COMBINATIONS IN ADVANCED PANCREATIC ADENOCARCINOMA: CISPLATIN, CAPECITABINE, GEMCITABINE PLUS EITHER EPIRUBICIN OR DOCETAXEL
Abstract
A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility
Articolo
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor
Articolo
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors
Articolo
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED, STAGE IV DIGESTIVE ENDOCRINE TUMORS
Articolo
ADJUVANT PEFG (CISPLATIN, EPIRUBICIN, 5-FLUOROURACIL, GEMCITABINE) OR GEMCITABINE IN PANCREATIC CANCER: A RANDOMIZED PHASE II TRIAL
Abstract
ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING A REDUCED INTENSITY CONDITIONING REGIMEN IN RELAPSED PERIPHERAL T-CELL LYMPHOMAS (PTCL): RESULTS AFTER A MEDIAN FOLLOW-UP OF 67 MONTHS
Articolo
AN ITALIAN SURVEY OF METASTATIC PANCREATIC ADENOCARCINOMA
Abstract
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer
Articolo
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients
Articolo
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab
Articolo
Analysis of local and regional recurrences in breast cancer after conservative surgery
Articolo
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma
Articolo
Array-CGH in diffuse large B-cell lymphomas (DLBCL) treated with R-CHOP identifies recurrent 11Q24.3 aberrations
Abstract
Associations between infectious agents and malt lymphoma of the ocular adnexa (OAL): Behavioral and therapeutic implications
Abstract
Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: post-progression outcomes from the phase II IMvigor210 study
Articolo
BONE MARROW INVOLVEMENT AND 7Q GAIN IN DIFFUSE LARGE B-CELL LYMPHOMA: A COMBINATION OF CLINICAL AND MOLECULAR DATA
Abstract
Bacteria-eradicating therapy for ocular adnexal MALT lymphoma: questions for an open international prospective trial
Articolo
Bcl2, Bcl6, MYC, MALT 1 and Bcl10 rearrangements in nodal diffuse large B-cell lymphomas: A multicenter evaluation of a new set of fish probes and correlation with clinical outcome
Abstract
Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma
Articolo
Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Articolo
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
Articolo
Brain metastases (BM) in locally advanced non-small cell lung cancer (LAD-NSCLC) after multimodality treatment (MMT): Risk factors analysis.
Articolo
Breast cancer subtypes and outcome after local and regional relapse
Articolo
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer
Articolo
CISPLATIN YIELDS HIGH RATE OF PATHOLOGIC COMPLETE RESPONSE (ypCR) IN COMBINATION WITH CAPECITEBINE AND PELVIC RADIATION IN THE NEOADJUVANT TREATMENT OF RECTAL CANCER
Abstract
CLINICAL PRESENTATION, BEHAVIOR, MANAGEMENT, AND OUTCOME OF AN INTERNATIONAL SERIES OF 40 CASES OF INTRAVASCULAR LYMPHOMA
Abstract
COMBINATION CHEMOTHERAPY (CHT) FOLLOWED BY CHEMORADIATION FOR STAGE III PANCREATIC ADENOCARCINOMA (PA)
Abstract
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
Articolo
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy
Articolo
Chemokine expression patterns in primary central nervous system lymphoma
Abstract
Chlamydia infection and lymphoma: Multiple detection methods highlight an association beyond lymphomas of the ocular adnexa
Abstract
Chlamydia psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma
Articolo
Chlamydophila psittaci (CP) is viable and infectious in the conjunctiva and peripheral blood of patients with ocular adnexal malt lymphoma (OAML): Results of a prospective trial
Abstract
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Articolo
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Articolo
Cisplatin plus capecitabine (CisCape) and concurrent pelvic radiotheapy for the neoadjuvant treatment of rectal cancer (RC)
Abstract
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion
Articolo
Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa
Articolo
Clinical implications of immunohistochemical assessment of somatostatin receptors subtype 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours
Abstract
Colorectal cancer screening by colonoscopy: One year experience in high and low risk population
Abstract
Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas
Articolo
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO
Articolo
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? [Ann Oncol, 23, 9, (2012) (2313-2318)] doi: 10.1093/annonc/mdr623
Articolo
Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study
Articolo
Definitive results of a phase II trial of PEF-G (cisplatin, epirubicin, 5-fluorouracil continous infusion, gemcitabine) in stage IV pancreatic adenocarcinoma
Abstract
Development of adaptive immune effector therapies in solid tumors
Articolo
Diagnostic and therapeutic management of carcinoma of unknown primary: Histopathological and molecular diagnosis
Articolo
Distribution of metastatic sites in renal cell carcinoma: a population-based analysis
Articolo
Does oxaliplatin and paclitaxel combination show an activity of some extent in pretreated patients with germ-cell tumors?
Articolo
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆
Articolo
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees
Articolo
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
Articolo
ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0
Articolo
ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)
Articolo
EXPOSURE TO ANIMALS AND RISK OF OCULAR ADNEXAL MARGINAL ZONE B-CELL LYMPHOMA
Abstract
Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects.
Articolo
Erratum: Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC) (Annals of Oncology (2018) 29(2) (361–369), (S0923753419350392), (10.1093/annonc/mdx692))
Articolo
Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center
Articolo
FUNCTIONAL CHARACTERIZATION OF AN 11Q24.3 GAIN CONTRIBUTING TO THE PATHOGENESIS OF DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) BY BLOCKING B-CELL MATURATION
Abstract
Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort
Articolo
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
Articolo
Final results of a phase II trial of raltitrexedeloxatin (TOM-OX) salvage chemotherapy in gemcitabine-refractory metastatic pancreatic cancer (PC)
Abstract
GENOMIC PROFILES OF MALT LYMPHOMAS: VARIABILITY ACROSS ANATOMIC SITES
Abstract
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Articolo
HER2-negative (1+) breast cancer with unfavorable prognostic features: To FISH or not to FISH?
Articolo
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib
Articolo
Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer
Articolo
High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): The HD-K phase II trial
Articolo
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study
Articolo
IMPACT OF CLINICAL PARAMETERS ON OUTCOME OF PATIENTS TREATED WITH GAMMA KNIFE STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
Contributo in Atti di convegno
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer
Articolo
Ibrutinib in Combination with Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients with Metastatic Pancreatic Adenocarcinoma: Phase 3 RESOLVE Study
Articolo
Identification of gene expression profiling to predict pathologic response of rectal carcinoma after preoperative chemoradiotherapy
Contributo in Atti di convegno
Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial.
Articolo
Immunogenicity and early clinical outcome after two or three doses of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: results from the prospective observational Vax-On-Third study
Articolo
Immunological differences between primary and metastatic breast cancer
Articolo
Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)
Articolo
Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study
Articolo
Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms.
Articolo
In reply to the letter to the editor 'in reply to Gandaglia et al.' by de Bari et al
Articolo
Intensified PEFG regimen in stage III-IV pancreatic adenocarcinoma: A phase I trial
Abstract
Intensity-modulated radiation therapy leads to survival benefit only in patients with high-risk prostate cancer: a population-based study
Articolo
Intra-arterial hepatic chemotherapy (IAHC) with a percutaneuos transaxillary placement of arterial device: Efficacy of an innovative approach
Articolo
Intravascular large B-cell lymphoma (IVLBCL): International consensus on diagnostic and therapeutic issues
Abstract
Introducing new molecular technologies into routine clinical cancer care: Is there an impact on the treatment of breast cancer?
Articolo
Introducing new molecular technologies into routine clinical cancer care: is there an impact on the treatment of breast cancer?
Articolo
Life expectancy of young adults with follicular lymphoma
Articolo
Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma.
Articolo
Long-term effects of inhaled budesonide on screening-detected lung nodules
Articolo
Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Articolo
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
Articolo
Malignant pleural effusion (MPE) characterized with 11C-Methionine PET/CT before and after talc pleurodesis: interim evaluation of a prospective clinical trial
Articolo
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
Articolo
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
Articolo
Modified cisplatin, etoposide, and ifosfamide (PEI) salvage therapy for male germ cell tumors: long-term efficacy and safety outcomes(dagger)
Articolo
Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study
Articolo
Neoadjuvant immunotherapy in triple-negative breast cancer: lesson learnt, remaining questions
Articolo
Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide
Articolo
New target therapies in advanced pancreatic cancer
Articolo
Non-gastric MALT lymphomas: a survey of 369 European patients - The International Extranodal Lymphoma Study Group (IELSG).
Abstract
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Articolo
Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy
Articolo
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Articolo
Oncologic outcome in laparoscopic and open total mesorectal excision
Abstract
Outcome of special types of luminal breast cancer
Articolo
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Articolo
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen in advanced biliary tract adenocarcinoma (BTA)
Articolo
PEFG REGIMEN (CISPLATIN, EPIRUBICIN, 5-FLUOROURACIL, GEMCITABINE) VERSUS GEMCITABINE (G): A PHASE III TRIAL IN ADVANCED PANCREATIC ADENOCARCINOMA (PA). TIME TO ABANDON SINGLE-AGENT THERAPY?
Articolo
PEFG salvage therapy in patients with gemcitabine-resistant advanced pancreatic cancer (PC)
Abstract
PEFG salvage therapy inpatients with gemcitabine-resistant advanced pancreatic cancer (PC)
Abstract
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients
Articolo
PREVALENCE OF CHLAMYDOPHILA PSITTACI AND BORRELIA BURGDORFERI INFECTIONS IN A SERIES OF 108 PRIMARY CUTANEOUS LYMPHOMAS
Abstract
Pancreatic cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
Articolo
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries
Articolo
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study
Articolo
Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapy
Articolo
Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trial
Articolo
Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study
Articolo
Pexg (P : Cisplatin, E : Epirubicin, X : Capecitabine, G : Gemcitabine) versus PDXG (D : Docetaxel) regimen in advanced pancreatic cancer: A randomized phase II trial
Abstract
Phase IV trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma
Abstract
Postpneumonectomy-like syndrome after chemoradiation therapy for lymphoma
Articolo
Preliminary data of a large study of high-resolution genome wide-DNA profiling in marginal zone lymphomas (MZL)
Abstract
Preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer
Abstract
Preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer
Abstract
Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas
Articolo
Primary brain CD30+ALK1+anaplastic large cell lymphoma ('ALKoma'): the first case with a combination of 'not common' variants
Articolo
Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
Articolo
Professional failure: how do oncologists feel it?
Articolo
Progesterone receptor loss identifies luminal B breast cancer subgroups at higher risk of relapse
Articolo
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer
Articolo
Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours.
Articolo
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing
Articolo
Prognostic value of carbohydrate antigen (CA) 19-9 decrease in response to chemotherapy for advanced pancreatic adenocarcinoma (PA)
Abstract
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
Articolo
Quality of life outcome in advanced pancreatic adenocarcinoma: results from a phase III trial
Abstract
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer
Articolo
RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE (HD-MTX) ALONE OR ASSOCIATED WITH HIGH-DOSE CYTARABINE (HD-ARAC) FOR PATIENTS WITH PRIMARY CNS LYMPHOMA (IELSG # 20 TRIAL): TOLERABILITY, ACTIVITY AND SURVIVAL ANALYSES
Abstract
Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial
Articolo
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes
Articolo
Randomized phase II trial on primary chemotherapy (CHT) with high-dose methotrexate (MTX) alone or associated with high-dose cytarabine (ARAC) for patients (PTS) with primary CNS lymphoma (PCNSL)
Abstract
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of > 2 years of follow-up
Articolo
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study
Articolo
Rectal cancer T staging: Role of endoscopic ultrasound (EUS) and computerized tomographic colonography (CTC)
Abstract
Red meat, Mediterranean diet and lung cancer risk among heavy smokers in the COSMOS screening study
Articolo
Relationships between YTNM and prognosis in advanced rectal cancer
Articolo
Relevance of intraocular involvement in the management of primary central nervous system lymphomas
Articolo
Reply to the article 'Hepatitis C virus (HCV) infection and MALT-type ocular adnexal lymphoma (OAL)' by P. Arnaud, M.-C. Escande, M. Lecuit et al.
Articolo
Rituximab improves outcome in Western patients with intravascular large B-cell lymphoma (IVL)
Abstract
Role of circulating tumour marker CA 19.9 and antiangiogenic therapy with bevacizumab in patients with metastatic colorectal cancer on first line systemic treatment
Abstract
SALVAGE THERAPY WITH MITOMYCIN AND IFOSFAMIDE (MI) IN PATIENTS WITH GEMCITABINE-RESISTANT METASTATIC PANCREATIC CANCER
Abstract
Salvage therapy in advanced pancreatic adenocarcinoma
Abstract
Second ESMO consensus conference on lung cancer: Pathology and molecular biomarkers for non-small-cell lung cancer
Articolo
Second-line single-agent versus doublet chemotherapy as salvage therapy for metastatic urothelial cancer: a systematic review and meta-analysis
Articolo
Selecting patients for resection after primary chemotherapy for non-metastatic pancreatic adenocarcinoma
Articolo
Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy
Articolo
Surgical strategy in the treatment of gastrointestinal neuroendocrine tumours
Articolo
Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma
Abstract
TEN-YEAR SAFETY AND EFFICACY ANALYSES OF THE BIG 02-98 PHASE III TRIAL WITH AN EXPLORATORY ANALYSIS ON THE ROLE OF KI67 IN PREDICTING BENEFIT OF ADJUVANT DOCETAXEL IN ER POSITIVE PATIENTS
Abstract
THE HIGH PREVALENCE OF CHLAMYDIA PSITTACI INFECTION IN OCULAR ADNEXAL LYMPHOMAS (OAL) PROVIDES THE RATIONALE FOR THE USE OF ANTIBIOTICS AS A POTENTIAL THERAPEUTIC STRATEGY IN THESE PATIENTS
Abstract
THE ROLE OF DEL(13Q14.3) IN DIFFUSE LARGE B-CELL LYMPHOMAS
Abstract
TUMOR DOWNSTAGING AND SPHINCTER PRESERVATION WITH PREOPERATIVE CHEMORADIOTHERAPY FOR RECTAL CANCER
Abstract
Temozolomide as salvage treatment in primary central nervous system lymphomas
Abstract
The current and future role of the medical oncologist in the professional care for cancer patients: A position paper by the European Society for Medical Oncology (ESMO)
Articolo
The role of consolidation radiotherapy in the management of stage III-IV diffuse large-cell lymphoma
Abstract
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): The MITO-9 study
Articolo
Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: Results of a critical review of the literature
Articolo
Therapeutic management of primary central nervous system lymphoma: Lessons from prospective trials
Articolo
Timing of response evaluation with 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant pleural mesothelioma (MPM): "Early'' versus "late'' assessment
Abstract
Treatment of squamous cell carcinoma of the anal canal (SCCA): A new era?
Articolo
Tumor mutational burden for the prediction of PD-(L)1 blockade efficacy in cancer: challenges and opportunities
Articolo
Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies
Articolo
Unavoidable mastectomy for ipsilateral breast tumour recurrence after conservative surgery: patient outcome
Articolo
Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023
Articolo
Unity is strength: one, two, or more drugs against advanced pancreatic cancer?
Articolo
Validation of the GELA scoring system for evaluating gastric biopsies from patients with MALT lymphoma following eradication of Helicobacter pylori
Abstract
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)
Articolo
Weekly docetaxel as salvage therapy in patients with gemcitabine-refractory metastatic pancreatic cancer
Abstract
Weekly epirubicin as salvage therapy inpatient with gemcitabine-refractory pancreatic cancer
Abstract
What can the pathologist offer for optimal treatment choice?
Articolo
What treatment in 2017 for inoperable pancreatic cancers?
Articolo
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial
Articolo
XELIRI OR FOLFIRI AS SALVAGE THERAPY IN ADVANCED PANCREATIC CANCER
Abstract
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
